The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional) |
93.242, 93.350, 93.853, 93.865 |
RFA-HD-20-003 |
| Combating Antibiotic-Resistant Bacteria (CARB) Interdisciplinary Research Units (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-001 |
| Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed) |
93.866 |
PAR-20-095 |
| Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) |
93.307, 93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-20-081 |
| NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed |
93.846 |
PAR-20-090 |
| Mendelian Genomics Data Coordinating Center (U24 Clinical Trial Not Allowed) |
93.172 |
RFA-HG-20-008 |
| New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-003 |
| Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional) |
93.173, 93.866 |
RFA-AG-21-011 |
| Mendelian Genomics Research Centers (U01 Clinical Trial Optional) |
93.172 |
RFA-HG-20-007 |
| Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) |
93.307, 93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-20-088 |
| Limited Competition: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-005 |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) |
93.352 |
PAR-20-086 |
| Infrastructure for the Expansion of Rhesus macaque Colonies to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) |
93.352 |
PAR-20-087 |
| MoTrPAc Phase 2 Animal Studies (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-009 |
| Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed) |
93.395 |
RFA-CA-20-032 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
93.242, 93.273 |
PAR-20-038 |
| Digital, Limited Interaction Trials and Epidemiology (D-LITE): Targeting HIV Incidence in the United States (U01 Clinical Trial Required) |
93.242, 93.855, 93.865 |
RFA-AI-19-067 |
| Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) |
93.351 |
RFA-OD-20-002 |
| Pilot Centers for Precision Disease Modeling (U54)(Clinical Trials Not Allowed) |
93.351 |
PAR-20-085 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) |
93.242, 93.273 |
PAR-20-037 |
| Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.242, 93.279, 93.350, 93.859 |
PA-20-025 |
| Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.242, 93.279, 93.350, 93.859, 93.867 |
PA-20-047 |
| NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
93.286 |
PAR-20-084 |
| Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) |
93.173, 93.242, 93.279, 93.853, 93.866, 93.867 |
PAR-20-082 |
| Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) |
93.173, 93.242, 93.279, 93.853, 93.866, 93.867 |
PAR-20-055 |
| Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-19-029 |
| New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-026 |
| Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-024 |
| BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-20-006 |
| Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required) |
93.847 |
RFA-DK-19-021 |
| White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed) |
93.853, 93.866 |
RFA-NS-20-013 |
| Surgical Disparities Research (R01 - Clinical Trial Optional) |
93.307 |
PAR-20-079 |
| Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21- Clinical Trials Not Allowed) |
93.242, 93.307, 93.399 |
RFA-MD-20-005 |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
93.394 |
RFA-CA-20-022 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
93.394 |
RFA-CA-20-026 |
| Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-007 |
| Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-008 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) |
93.394 |
RFA-CA-20-023 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
93.394 |
RFA-CA-20-024 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
93.394 |
RFA-CA-20-021 |
Search Results 3041-3080 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
